Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 603 across all filing types
Latest filing 2023-10-12 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return related to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It details multiple repurchases of shares over various dates, including quantities and prices. The document references compliance with listing rules of the Stock Exchange of Hong Kong and provides confirmations related to share repurchases. The content is focused on reporting share repurchase transactions and changes in issued shares, which aligns with the category of Transaction in Own Shares (POS). The document is lengthy (15,000 characters) and contains detailed transactional data, not merely an announcement or a brief summary, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the appropriate classification is POS with high confidence.
2023-10-12 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares with dates and quantities, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The content focuses on share repurchase activities and changes in issued shares, with no financial statements or earnings data. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document is lengthy (15,000 characters) and contains detailed transactional data, not just an announcement or summary, so it is not a report publication announcement or regulatory filing. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2023-10-11 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares with dates and quantities, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The content focuses on reporting share repurchase transactions and changes in issued shares, with no financial statements or earnings data. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, not just an announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2023-10-10 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares on various dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The content focuses on share repurchase transactions, quantities, prices, and confirmations related to these transactions. There is no indication of this being a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure of share repurchase activity. According to the filing definitions, reports of the company buying back or selling its own shares (share repurchase/issuance) fall under 'Transaction in Own Shares' (POS). The document length is substantial and contains detailed transactional data, not merely an announcement or certification, so it is not RNS or RPA. Therefore, the correct classification is POS with high confidence.
2023-10-09 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is a detailed disclosure return related to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes extensive data on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The document is regulatory in nature, reporting share repurchase transactions and capital changes, but it is not a financial report, earnings release, or management discussion. It is not a proxy, AGM material, or legal proceeding. The content fits the category of a report on transactions in own shares (share buybacks). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence score.
2023-10-06 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It references specific rules from the Stock Exchange of Hong Kong (Main Board Listing Rules and GEM Rules) and details numerous repurchases of shares with dates and quantities. The document includes confirmations about compliance with listing rules and legal requirements related to share repurchases. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure about share repurchases and changes in issued share capital. This fits the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback activities. The document length and detail confirm it is the report itself, not just an announcement of a report. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2023-10-05 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.